HCV-IN-29
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e[1].
Product Specifications
CAS Number
[1009119-83-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hcv-in-29.html
Purity
99.99
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
[H][C@]1(CCCN1)C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@]6([H])CCCN6)N5)C=C4)C=C3)N2.Cl.Cl.Cl.Cl
Molecular Formula
C26H32Cl4N6
Molecular Weight
570.38
Precautions
H302, H315, H319, H335
References & Citations
[1]Makonen Belema, et al. Hepatitis C virus inhibitors. US8329159B2.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
